Pharmaceuticals Fighting Diseases Health at Bayer Pharmaceuticals Treatments & Therapies Cardiology Thrombosis Heart Attack Diagnosing Heart Disease Heart Failure High Blood Pressure Stroke & Atrial Fibrillation Hematology Oncology Gastrointestinal Stromal Tumor Breast Cancer Kidney Cancer Liver Cancer Prostate Cancer TRK Fusion Cancer Thyroid Cancer Chronic Kidney Disease Eye Conditions Age-related Macular Degeneration Diabetic Macular Edema Healthy Aging Hormonal & Reproductive Health Contraception Endometriosis Heavy Menstrual Bleeding Menopause Uterine Fibroids Acne Therapy Innovation & Technologies Trends AAV Therapeutics Stem cells - The new age of medical research Pharmacogenetics Biomarkers Precision Medicine Unlocking the Undruggable Space Pipeline Clinical Trials Worldwide Standards Ethics in Clinical Trials FAQ Access to investigational medicines Technology Chemoproteomics PROTAC's RNA-targeting SMOLs Diagnostic Imaging AI Technology Digitalization in Drug Discovery Partnering Areas of Interest Why We Partner Partnering With us Chemical Probes For Open Access Sustainability Patient Access Charter Leadership Perspective Strengthening Healthcare Access Empowering Women, Globally Empowering Her, Health for All Real Life Stories Fighting Neglected Tropical Diseases Chagas Disease Moving Non-Communicable Diseases Care Forward Ensuring a Sustainable Product Supply Delivering Better Cancer Care Transparency Patient Organization Patient Engagement News & Stories Clinical Trials Explorer Transparency Policy Personal Health Solutions Aiding Digestion Caring for Skin Fighting Pain Protecting Heart Health Relieving Allergies Supporting Nutrition Treating Cold and Flu Symptoms Products Innovation Partnerships Trust and Credibility Science-Led Self-Care Our Commitments Creative and Responsible Marketing Empowering Personal Health Sustainably Inspiring Creativity and Improving Health The Nutrient Gap Initiative Report a Side Effect Medical Counterfeits Recognizing Fakes EU Verification Logo against Counterfeit Drugs Background Information Recognizing Fraudulent Brands Links New Safety Features for Prescription Medicine in Europe Commitment to Fighting Counterfeit Drugs I am a Patient LEARN MORE I am a Professional LEARN MORE I am a Partner LEARN MORE We Care 01:30 00:00 Latest News January 27, 2023 Not intended for U.S. and UK Media CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer READ MORE January 24, 2023 Aleksandra Rizo Appointed as CEO of Vividion Therapeutics READ MORE January 23, 2023 Not intended for U.S. and UK Media Ultravist™ by Bayer now approved for contrast-enhanced mammography in EU READ MORE NEWS OVERVIEW Engagement 30 Years From Now READ MORE Innovation Development Pipeline READ MORE Update on Covid-19 Our Commitment During the Coronavirus Pandemic READ MORE twitter BayerPharma Friday, January 27, 2023 #NEWS Today, we welcome the positive #CHMP opinion for our metastatic hormone-sensitive #ProstateCancer treatment,… https://t.co/qKZJlLwTfL READ MORE #WeWontRest For a brighter tomorrow #WeWontRest READ MORE Bayer Clinical Trials READ MORE Explore Your Topic Cancer READ MORE Innovation and Research READ MORE Sustainable Healthcare READ MORE Our Engagement READ MORE Innovation Pipeline Insights Stories READ MORE Global Health Policy Blog HEALTH POLICY INSIGHTS The Promise of Digital Health READ MORE HEALTH POLICY INSIGHTS The Economic And Societal Impact of Cardiovascular Disease READ MORE HEALTH POLICY INSIGHTS The Expert Patient READ MORE VISIT BLOG
